Epigenetics Market by Product (Kits, Reagents, Enzymes, Instruments and Services) Technology (DNA Methylation, and Histone Modifications), Application (Oncology, Developmental Biology, Cardiovascular Diseases, Metabolic Diseases and Immunology) and Region - Analysis & Forecast 2019-2030

Report ID : 27  |  Published Date : Feb 2019  |  Pages : 150  |  Region : global  |  Report Code : BT-7


Epigenetics Market Overview and Introduction

Epigenetics can be defined as the study of heritable changes which occur during the expression of genes, this changes do not led to alteration of underlying DNA sequences. It further involves the study of variations in physiological and cellular traits, in response to environmental or external stimuli. Alternations in epigenetics, leads to changes in the phenotype, whereas, the concerned genotype remains unaltered, i.e. constant. Changes in epigenetics are influenced by a broad range of factors, namely surrounding environment, age, disease state, lifestyle and others.

The global epigenetics market is driven by technological advancements in the genomics arena, increasing research expenditure in genetics, reduced price of DNA sequencing and incidences of cancer. However, high costs of epigenetic instruments is anticipated to somewhat restrict the lucrative growth of the epigenetics market during the forecast period.

Epigenetics Market by Product, Application and Technology

On the basis of product, the epigenetics market is segmented into kits, reagents, enzymes, instruments and services. The kits segment is further segmented into whole genomic amplification kit, RNA sequencing kit, chip sequencing kit, bisulfite conversion kit and others. Kits accounted for the largest share of the market owing to growing number of research on genetic and rising prevalence of several forms of diseases. Based on technology, the market is segmented into DNA methylation, histone modifications, and other technologies. The DNA methylation segment is estimated to account for the largest share of the global epigenetics market. The large share of this segment can be attributed to the technological advancement in DNA methylation techniques and PCR instrument. On the basis of application, the epigenetics market is segmented into oncology, developmental biology, cardiovascular diseases, metabolic diseases, immunology and other applications. The oncology segment is estimated to account for the largest share of the epigenetics market. Epigenetics is extensively used to derive strategies for oncology therapeutics to reverse the abnormalities in transcription.  

Epigenetics Market by Regions 

The global epigenetics market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW).  North America dominated the market of epigenetics, followed by Europe and Asia Pacific. North America will continue to dominate the global epigenetics market in the forecast period owing to factors such as highly developed R&D scenario and presence of private and public funding. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the epigenetics market in this region.

Epigenetics Market Prominent Players 

The prominent players in the global epigenetics market are Agilent Technologies, Thermo Fisher Scientific, Illumina, QIAGEN N.V., PerkinElmer, Merck KGaA, Abcam plc. , Active Motif,  Bio-Rad Laboratories, Inc. , New England Biolabs and, Zymo Research  among others.

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1.   Market Classification
      2.   Geographic Scope
      3.   Years Considered for the Study
        1. Historical Years – 2016 & 2017
        2. Base Year – 2018
        3. Forecasted Years – 2019 to 2030
    3. Currency Used for the Study
    4. Report Beneficiary List
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technology
    3. Data Sources
      1.  Secondary Sources
      2.  Primary Sources
    4. Market Estimation Methodology
      1.   Bottoms Up Approach
      2.   Top Down Approach
    5. Data Validation and Triangulation
      1.   Market Forecasting Model
      2.   Limitations of the Study
      3.   Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Technological Advancement
    2. Application Horizon Assessment
    3. Initiatives Assessment: Government & Private Bodies
  6. Global Epigenetics Market - Analysis & Forecast, By Product
    1. Introduction 
    2. Kits
    3. Reagents
    4. Enzymes
    5. Instruments
    6. Services 
  7. Global Epigenetics Market - Analysis & Forecast, By Technology
    1. Introduction & Definition
    2. Reagents & Kits
    3. Instruments
    4. Epigenetics Services 
  8. Global Epigenetics Market - Analysis & Forecast, By Application
    1. Introduction 
    2. Oncology
    3. Developmental Biology
    4. Cardiovascular Diseases
    5. Metabolic Diseases
    6. Immunology
    7. Other Application
  9. Global Epigenetics Market - Analysis & Forecast, By Region
    1.     North America Epigenetics Market
      1.   North America Epigenetics Market, By Country
        1.  US
        2.  Canada
      2. North America Epigenetics Market Analysis & Forecast, By Product
      3. North America Epigenetics Market Analysis & Forecast, By Technology
      4. North America Epigenetics Market Analysis & Forecast, By Application
    2. Europe Epigenetics Market
      1. Europe Epigenetics Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Epigenetics Market Analysis & Forecast, By Product
      3. Europe Epigenetics Market Analysis & Forecast, By  Technology
      4. Europe Epigenetics Market Analysis & Forecast, By Application
    3. Asia Pacific Epigenetics Market
      1. Asia Pacific Epigenetics Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Epigenetics Market Analysis & Forecast, By Product  
      3. Asia Pacific Epigenetics Market Analysis & Forecast, By  Technology
      4. Asia Pacific Epigenetics Market Analysis & Forecast, By Application
    4.    Rest of the World (ROW) Epigenetics Market
      1. Rest of the World Epigenetics Market, By Country/ Region
        1.  Latin America
        2.  Middle East & Africa
      2. Rest of the World Epigenetics Market Analysis & Forecast, By  Product
      3. Rest of the World Epigenetics Market Analysis & Forecast, By  Technology
      4. Rest of the World Epigenetics Market Analysis & Forecast, By Application
  10. COMPETETIVE LANDSCAPE
    1. Market Share Analysis (2018)
    2. Key Strategies Assessment.
      1. New Product Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Other Strategies
  11. COMPANY PROFILES  (Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
    1.    Agilent Technologies
    2.    Thermo Fisher Scientific
    3.    Illumina
    4.    QIAGEN N.V.
    5.     PerkinElmer
    6.    Merck KGaA
    7.    Abcam plc.
    8.    Active Motif
    9.    Bio-Rad Laboratories, Inc.
    10. New England Biolabs (*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
  12. APPENDIX
    1. Questionnaire
    2. Primary Interviews Transcripts
    3.    Customization Options
    4. Profile of the Author